HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiro Hayakawa Selected Research

ethyl 4-methoxycinnamate

2/2022Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiro Hayakawa Research Topics

Disease

86Neoplasms (Cancer)
10/2022 - 01/2002
33Neoplasm Metastasis (Metastasis)
02/2022 - 01/2003
19Breast Neoplasms (Breast Cancer)
12/2021 - 08/2004
11Melanoma (Melanoma, Malignant)
02/2022 - 11/2005
11Bites and Stings (Sting)
01/2021 - 02/2011
10Infections
01/2022 - 08/2003
8Lung Neoplasms (Lung Cancer)
10/2019 - 08/2009
5Lymphoma (Lymphomas)
01/2018 - 01/2004
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2014
4Inflammation (Inflammations)
09/2016 - 12/2004
4Sarcoma (Soft Tissue Sarcoma)
06/2007 - 08/2003
3Autoimmune Diseases (Autoimmune Disease)
06/2018 - 08/2003
3Carcinoma (Carcinomatosis)
01/2017 - 08/2003
3Bacterial Infections (Bacterial Infection)
04/2015 - 08/2008
3Carcinogenesis
09/2005 - 08/2003
2Neuroblastoma
06/2022 - 04/2005
2Prostatic Neoplasms (Prostate Cancer)
06/2022 - 10/2004
2Necrosis
12/2020 - 10/2019
2Communicable Diseases (Infectious Diseases)
06/2018 - 08/2008
2Fibrosarcoma
01/2017 - 09/2005
2Obesity
01/2015 - 01/2010
2Staphylococcal Infections
07/2009 - 02/2007
2Mastitis
08/2005 - 03/2005
1Hepatoblastoma
06/2022
1Colorectal Neoplasms (Colorectal Cancer)
06/2022
1COVID-19
01/2022

Drug/Important Bio-Agent (IBA)

23LigandsIBA
12/2021 - 01/2002
14bis(3',5')-cyclic diguanylic acidIBA
10/2015 - 03/2005
13CytokinesIBA
06/2018 - 10/2004
11InterferonsIBA
01/2021 - 01/2002
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013 - 01/2002
9Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2003
9Pharmaceutical PreparationsIBA
07/2021 - 04/2005
9PerforinIBA
01/2009 - 11/2002
8Interleukin-12 (IL 12)IBA
09/2014 - 04/2002
7alpha-galactosylceramideIBA
12/2005 - 04/2002
6DNA (Deoxyribonucleic Acid)IBA
06/2014 - 02/2011
5AntigensIBA
06/2020 - 06/2014
5MethylcholanthreneIBA
06/2007 - 01/2002
4Peptides (Polypeptides)IBA
10/2022 - 11/2005
4Indicators and Reagents (Reagents)IBA
11/2020 - 06/2014
4PhytochemicalsIBA
01/2020 - 11/2014
4Phosphotransferases (Kinase)IBA
07/2016 - 02/2009
4TNF-Related Apoptosis-Inducing LigandIBA
09/2013 - 01/2003
4interleukin-21 (interleukin 21)IBA
05/2006 - 02/2004
3NF-kappa B (NF-kB)IBA
09/2021 - 01/2010
3Biological ProductsIBA
01/2021 - 03/2014
3InterleukinsIBA
01/2021 - 11/2004
3Proteasome Endopeptidase Complex (Proteasome)IBA
11/2020 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
01/2018 - 04/2015
3hirsutineIBA
07/2016 - 11/2014
3Interferon Type IIBA
10/2015 - 02/2011
3Monoclonal AntibodiesIBA
09/2013 - 01/2002
3Histocompatibility Antigens Class IIBA
06/2012 - 01/2006
3AntibodiesIBA
05/2010 - 01/2003
3Vaccine AdjuvantsIBA
07/2009 - 10/2007
3NK Cell Lectin-Like Receptor Subfamily KIBA
09/2005 - 11/2002
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2022 - 11/2005
2AlkaloidsIBA
06/2022 - 07/2016
2LuciferasesIBA
01/2022 - 04/2017
2Lipid NanoparticlesIBA
01/2022 - 01/2021
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2021 - 01/2020
2Neoplasm Antigens (Tumor Antigens)IBA
09/2021 - 06/2020
2Interferon-gamma (Interferon, gamma)IBA
04/2021 - 11/2005
2MAP Kinase Kinase Kinase 5IBA
04/2021 - 12/2017
2UbiquitinIBA
11/2020 - 04/2018
2Deubiquitinating EnzymesIBA
11/2020 - 04/2018
2Thalidomide (Thalomid)FDA Link
08/2020 - 08/2007
2CarcinogensIBA
11/2019 - 01/2002
2Paclitaxel (Taxol)FDA LinkGeneric
02/2018 - 01/2013
2Aldo-Keto ReductasesIBA
01/2018 - 10/2017
2BerberineIBA
07/2017 - 09/2013
2Connective Tissue Growth FactorIBA
10/2016 - 01/2016
2Amino AcidsFDA Link
01/2016 - 11/2005
2Tyrosine Kinase InhibitorsIBA
01/2016 - 07/2014
2Gefitinib (Iressa)FDA Link
01/2016 - 07/2014
2ErbB Receptors (EGF Receptor)IBA
01/2016 - 07/2014
2YSK05IBA
10/2015 - 06/2014
2Liposomes (Liposome)IBA
10/2015 - 06/2014
2SurvivinIBA
09/2014 - 08/2014
2Nucleic AcidsIBA
11/2012 - 09/2011
2LectinsIBA
10/2011 - 11/2004
2NucleotidesIBA
09/2011 - 02/2011
2N,N'- dipyridoxylethylenediamine- N,N'- diacetic acid (PLED)IBA
08/2010 - 02/2009
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2010 - 02/2004
2Fas Ligand Protein (Fas Ligand)IBA
01/2009 - 11/2004
2Immunologic Factors (Immunomodulators)IBA
08/2008 - 10/2007
2Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2005 - 01/2004
2GpGpIBA
08/2005 - 04/2005
2Anti-Infective Agents (Microbicides)IBA
04/2005 - 03/2005
2Interleukin-18 (Interleukin 18)IBA
11/2004 - 03/2004
2Death Domain ReceptorsIBA
10/2004 - 01/2003
1HLA-A24 AntigenIBA
10/2022
1Chimeric Antigen ReceptorsIBA
10/2022
1acridoneIBA
06/2022
1ethyl 4-methoxycinnamateIBA
02/2022

Therapy/Procedure

24Therapeutics
01/2022 - 11/2002
19Immunotherapy
10/2022 - 04/2002
6Drug Therapy (Chemotherapy)
02/2022 - 01/2013
2Traditional Medicine (Folk Remedies)
04/2021 - 12/2013